{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:38Z","timestamp":1793413478253,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03550-w","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T21:12:24Z","timestamp":1756156344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fueling the brain - the role of apolipoprotein E in brain energy metabolism and its implications for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Vanessa","family":"Budny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3985-384X","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ruminot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Wybitul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-3031","authenticated-orcid":false,"given":"Valerie","family":"Treyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-4833","authenticated-orcid":false,"given":"L. Felipe","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-3055","authenticated-orcid":false,"given":"Christian","family":"Tackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"3550_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2022.102668","volume":"78","author":"Z Padamsey","year":"2023","unstructured":"Padamsey Z, Rochefort NL. Paying the brain\u2019s energy bill. Curr Opin Neurobiol. 2023;78:102668.","journal-title":"Curr Opin Neurobiol"},{"key":"3550_CR2","unstructured":"World Health Organization (WHO). Key facts Dementia. 2025 https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"3550_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"Alzheimer\u2019s Association.","year":"2021","unstructured":"Alzheimer\u2019s Association. 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2021;17:327\u2013406.","journal-title":"Alzheimers Dement"},{"key":"3550_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40035-019-0161-0","volume":"8","author":"SM de Leeuw","year":"2019","unstructured":"de Leeuw SM, Tackenberg C. Alzheimer\u2019s in a dish \u2013 induced pluripotent stem cell-based disease modeling. Transl Neurodegener. 2019;8:21.","journal-title":"Transl Neurodegener"},{"key":"3550_CR5","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"J Andrade-Guerrero","year":"2023","unstructured":"Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodr\u00edguez I, Cadena-Su\u00e1rez AR, S\u00e1nchez-Garibay C, et al. Alzheimer\u2019s disease: an updated overview of its genetics. Int J Mol Sci. 2023;24:3754.","journal-title":"Int J Mol Sci"},{"key":"3550_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"3550_CR7","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","volume":"19","author":"JJ Corneveaux","year":"2010","unstructured":"Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, et al. Association of CR1, CLU and PICALM with Alzheimer\u2019s disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010;19:3295\u2013301.","journal-title":"Hum Mol Genet"},{"key":"3550_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/ddm031","volume":"16","author":"A Grupe","year":"2007","unstructured":"Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, et al. Evidence for novel susceptibility genes for late-onset Alzheimer\u2019s disease from a genome-wide association study of putative functional variants. Hum Mol Genet. 2007;16:865\u201373.","journal-title":"Hum Mol Genet"},{"key":"3550_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","volume":"10","author":"DM Michaelson","year":"2014","unstructured":"Michaelson DM. APOE \u03b54: the most prevalent yet understudied risk factor for Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:861\u20138.","journal-title":"Alzheimers Dement"},{"key":"3550_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology. 1993;43:1467\u201372.","journal-title":"Neurology"},{"key":"3550_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","volume":"30","author":"J Fortea","year":"2024","unstructured":"Fortea J, Pegueroles J, Alcolea D, Belbin O, Dols-Icardo O, Vaqu\u00e9-Alc\u00e1zar L, et al. APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med. 2024;30:1284\u201391.","journal-title":"Nat Med"},{"key":"3550_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180\u20134.","journal-title":"Nat Genet"},{"key":"3550_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278:1349\u201356.","journal-title":"JAMA"},{"key":"3550_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, et al. Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11:667.","journal-title":"Nat Commun"},{"key":"3550_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron. 2021;109:205\u201321.","journal-title":"Neuron"},{"key":"3550_CR17","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","volume":"257","author":"SC Rall","year":"1982","unstructured":"Rall SC, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem. 1982;257:4171\u20138.","journal-title":"J Biol Chem"},{"key":"3550_CR18","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","volume":"256","author":"KH Weisgraber","year":"1981","unstructured":"Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256:9077\u201383.","journal-title":"J Biol Chem"},{"key":"3550_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1326-1-15","volume":"1","author":"GW Rebeck","year":"2006","unstructured":"Rebeck GW, LaDu MJ, Estus S, Bu G, Weeber EJ. The generation and function of soluble apoE receptors in the CNS. Mol Neurodegener. 2006;1:15.","journal-title":"Mol Neurodegener"},{"key":"3550_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med. 2016;94:739\u201346.","journal-title":"J Mol Med"},{"key":"3550_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1073\/pnas.82.1.203","volume":"82","author":"NA Elshourbagy","year":"1985","unstructured":"Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA. 1985;82:203\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR22","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006;26:4985\u201394.","journal-title":"J Neurosci"},{"key":"3550_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"3550_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.stemcr.2021.11.007","volume":"17","author":"SM de Leeuw","year":"2022","unstructured":"de Leeuw SM, Kirschner AWT, Lindner K, Rust R, Budny V, Wolski WE, et al. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes. Stem Cell Rep. 2022;17:110\u201326.","journal-title":"Stem Cell Rep"},{"key":"3550_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2019.00014","volume":"11","author":"CG Fernandez","year":"2019","unstructured":"Fernandez CG, Hamby ME, McReynolds ML, Ray WJ. The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:14.","journal-title":"Front Aging Neurosci"},{"key":"3550_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.14348\/molcells.2014.0248","volume":"37","author":"J Kim","year":"2014","unstructured":"Kim J, Yoon H, Basak J, Kim J. Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms. Mol Cells. 2014;37:767\u201376.","journal-title":"Mol Cells"},{"key":"3550_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507\u201337.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3550_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YWA Huang","year":"2017","unstructured":"Huang YWA, Zhou B, Wernig M, S\u00fcdhof TC. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell. 2017;168:427\u201341.e21.","journal-title":"Cell"},{"key":"3550_CR29","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3:89ra57.","journal-title":"Sci Transl Med"},{"key":"3550_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20:68\u201380.","journal-title":"Lancet Neurol"},{"key":"3550_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2021.158980","volume":"1866","author":"AB Chai","year":"2021","unstructured":"Chai AB, Lam HHJ, Kockx M, Gelissen IC. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-\u03b2. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866:158980.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"3550_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fern\u00e1ndez-Calle","year":"2022","unstructured":"Fern\u00e1ndez-Calle R, Konings SC, Fronti\u00f1\u00e1n-Rubio J, Garc\u00eda-Revilla J, Camprub\u00ed-Ferrer L, Svensson M, et al. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener. 2022;17:62.","journal-title":"Mol Neurodegener"},{"key":"3550_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jon.12601","volume":"29","author":"P Alongi","year":"2019","unstructured":"Alongi P, Sardina DS, Coppola R, Scalisi S, Puglisi V, Arnone A, et al. 18F-Florbetaben PET\/CT to assess Alzheimer\u2019s disease: a new analysis method for regional amyloid quantification. J Neuroimaging. 2019;29:383\u201393.","journal-title":"J Neuroimaging"},{"key":"3550_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00259-018-4149-2","volume":"46","author":"A Ciarmiello","year":"2019","unstructured":"Ciarmiello A, Tartaglione A, Giovannini E, Riondato M, Giovacchini G, Ferrando O, et al. Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer\u2019s disease in mild cognitive impairment patients. Eur J Nucl Med Mol Imaging. 2019;46:288\u201396.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3550_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12149-017-1154-7","volume":"31","author":"T Miki","year":"2017","unstructured":"Miki T, Shimada H, Kim JS, Yamamoto Y, Sugino M, Kowa H, et al. Brain uptake and safety of flutemetamol F 18 injection in Japanese subjects with probable Alzheimer\u2019s disease, subjects with amnestic mild cognitive impairment and healthy volunteers. Ann Nucl Med. 2017;31:260\u201372.","journal-title":"Ann Nucl Med"},{"key":"3550_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12149-018-1236-1","volume":"32","author":"T Higashi","year":"2018","unstructured":"Higashi T, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Okina T, et al. 18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia. Ann Nucl Med. 2018;32:206\u201316.","journal-title":"Ann Nucl Med"},{"key":"3550_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13195-020-00710-6","volume":"12","author":"MS Baek","year":"2020","unstructured":"Baek MS, Cho H, Lee HS, Lee JH, Ryu YH, Lyoo CH. Effect of APOE \u03b54 genotype on amyloid-\u03b2 and tau accumulation in Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12:140.","journal-title":"Alzheimers Res Ther"},{"key":"3550_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cca.2019.02.005","volume":"492","author":"C Bouter","year":"2019","unstructured":"Bouter C, Vogelgsang J, Wiltfang J. Comparison between amyloid-PET and CSF amyloid-\u03b2 biomarkers in a clinical cohort with memory deficits. Clin Chim Acta. 2019;492:62\u20138.","journal-title":"Clin Chim Acta"},{"key":"3550_CR39","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","volume":"72","author":"A Drzezga","year":"2009","unstructured":"Drzezga A, Grimmer T, Henriksen G, M\u00fchlau M, Perneczky R, Miederer I, et al. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology. 2009;72:1487\u201394.","journal-title":"Neurology"},{"key":"3550_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","volume":"13","author":"CR Jack","year":"2014","unstructured":"Jack CR, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, et al. Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. Lancet Neurol. 2014;13:997\u20131005.","journal-title":"Lancet Neurol"},{"key":"3550_CR41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-181282","volume":"69","author":"JB Toledo","year":"2019","unstructured":"Toledo JB, Habes M, Sotiras A, Bjerke M, Fan Y, Weiner MW, et al. APOE effect on amyloid-\u03b2 PET spatial distribution, deposition rate, and cut-points. J Alzheimers Dis. 2019;69:783\u201393.","journal-title":"J Alzheimers Dis"},{"key":"3550_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnagi.2013.00011","volume":"5","author":"SL Risacher","year":"2013","unstructured":"Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci. 2013;5:11.","journal-title":"Front Aging Neurosci"},{"key":"3550_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67:122\u201331.","journal-title":"Ann Neurol"},{"key":"3550_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2967\/jnumed.107.045385","volume":"49","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias. J Nucl Med. 2008;49:390\u20138.","journal-title":"J Nucl Med"},{"key":"3550_CR45","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2009;36:811\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3550_CR46","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/brain\/awm177","volume":"130","author":"NL Foster","year":"2007","unstructured":"Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain. 2007;130:2616\u201335.","journal-title":"Brain"},{"key":"3550_CR47","doi-asserted-by":"crossref","unstructured":"Mosconi L, Tsui WH, Pupi A, De Santi S, Drzezga A, Minoshima S, et al. 18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer\u2019s disease. J Nucl Med. 2007;48:1129\u201334.","DOI":"10.2967\/jnumed.107.040675"},{"key":"3550_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/CON.0000000000000700","volume":"25","author":"GD Rabinovici","year":"2019","unstructured":"Rabinovici GD. Late-onset Alzheimer disease. Continuum. 2019;25:14\u201333.","journal-title":"Continuum"},{"key":"3550_CR49","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11307-018-1167-1","volume":"20","author":"A Chiaravalloti","year":"2018","unstructured":"Chiaravalloti A, Castellano AE, Ricci M, Barbagallo G, Sannino P, Ursini F, et al. Coupled imaging with [18F]FBB and [18F]FDG in AD subjects show a selective association between amyloid burden and cortical dysfunction in the brain. Mol Imaging Biol. 2018;20:659\u201366.","journal-title":"Mol Imaging Biol"},{"key":"3550_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","volume":"69","author":"W Jagust","year":"2007","unstructured":"Jagust W, Reed B, Mungas D, Ellis W, Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology. 2007;69:871\u20137.","journal-title":"Neurology"},{"key":"3550_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nicl.2018.01.019","volume":"18","author":"SP Caminiti","year":"2018","unstructured":"Caminiti SP, Ballarini T, Sala A, Cerami C, Presotto L, Santangelo R, et al. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage Clin. 2018;18:167\u201377.","journal-title":"NeuroImage Clin"},{"key":"3550_CR52","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/JAD-170852","volume":"63","author":"CM Stonnington","year":"2018","unstructured":"Stonnington CM, Chen Y, Savage CR, Lee W, Bauer RJ, Sharieff S, et al. Predicting imminent progression to clinically significant memory decline using volumetric MRI and FDG PET. J Alzheimers Dis. 2018;63:603\u201315.","journal-title":"J Alzheimers Dis"},{"key":"3550_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3174\/ajnr.A1357","volume":"30","author":"Y Yuan","year":"2009","unstructured":"Yuan Y, Gu ZX, Wei WS. Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol. 2009;30:404\u201310.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3550_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2967\/jnumed.119.230797","volume":"61","author":"G Blazhenets","year":"2020","unstructured":"Blazhenets G, Ma Y, S\u00f6rensen A, Schiller F, R\u00fccker G, Eidelberg D, et al. Predictive Value of 18F-Florbetapir and 18F-FDG PET for conversion from mild cognitive impairment to Alzheimer dementia. J Nucl Med. 2020;61:597\u2013603.","journal-title":"J Nucl Med"},{"key":"3550_CR55","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s00259-018-3983-6","volume":"45","author":"L Frings","year":"2018","unstructured":"Frings L, Hellwig S, Bormann T, Spehl TS, Buchert R, Meyer PT. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer\u2019s dementia in a memory clinic population. Eur J Nucl Med Mol Imaging. 2018;45:1442\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3550_CR56","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3233\/JAD-215059","volume":"86","author":"SR Alves","year":"2022","unstructured":"Alves SR, da Cruz e Silva C, Rosa IM, Henriques AG, da Cruz e Silva OAB. A Bioinformatics approach toward unravelling the synaptic molecular crosstalk between Alzheimer\u2019s disease and diabetes. J Alzheimers Dis. 2022;86:1917\u201333.","journal-title":"J Alzheimers Dis"},{"key":"3550_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64\u201374.","journal-title":"Lancet Neurol"},{"key":"3550_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1104985","volume":"17","author":"E Gr\u00fcnblatt","year":"2023","unstructured":"Gr\u00fcnblatt E, Homolak J, Babic Perhoc A, Davor V, Knezovic A, Osmanovic Barilar J, et al. From attention-deficit hyperactivity disorder to sporadic Alzheimer\u2019s disease-Wnt\/mTOR pathways hypothesis. Front Neurosci. 2023;17:1104985.","journal-title":"Front Neurosci"},{"key":"3550_CR59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","volume":"6","author":"C Sims-Robinson","year":"2010","unstructured":"Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol. 2010;6:551\u20139.","journal-title":"Nat Rev Neurol"},{"key":"3550_CR60","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s001250050588","volume":"39","author":"A Ott","year":"1996","unstructured":"Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia. 1996;39:1392\u20137.","journal-title":"Diabetologia"},{"key":"3550_CR61","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.3390\/ijms24076586","volume":"24","author":"T Dakic","year":"2023","unstructured":"Dakic T, Jevdjovic T, Lakic I, Ruzicic A, Jasnic N, Djurasevic S, et al. The expression of insulin in the central nervous system: what have we learned so far? Int J Mol Sci. 2023;24:6586.","journal-title":"Int J Mol Sci"},{"key":"3550_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0031-9384(04)00348-8","volume":"83","author":"U Stockhorst","year":"2004","unstructured":"Stockhorst U, de Fries D, Steingrueber HJ, Scherbaum WA. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav. 2004;83:47\u201354.","journal-title":"Physiol Behav"},{"key":"3550_CR63","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","volume":"166","author":"C Garc\u00eda-C\u00e1ceres","year":"2016","unstructured":"Garc\u00eda-C\u00e1ceres C, Quarta C, Varela L, Gao Y, Gruber T, Legutko B, et al. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell. 2016;166:867\u201380.","journal-title":"Cell"},{"key":"3550_CR64","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98:2133\u2013223.","journal-title":"Physiol Rev"},{"key":"3550_CR65","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41574-021-00498-x","volume":"17","author":"T Scherer","year":"2021","unstructured":"Scherer T, Sakamoto K, Buettner C. Brain insulin signalling in metabolic homeostasis and disease. Nat Rev Endocrinol. 2021;17:468\u201383.","journal-title":"Nat Rev Endocrinol"},{"key":"3550_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-022-00235-8","volume":"8","author":"Z Wang","year":"2022","unstructured":"Wang Z, Tang X, Swaminathan SK, Kandimalla KK, Kalari KR. Mapping the dynamics of insulin-responsive pathways in the blood-brain barrier endothelium using time-series transcriptomics data. NPJ Syst Biol Appl. 2022;8:29.","journal-title":"NPJ Syst Biol Appl"},{"key":"3550_CR67","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103\u201323.","journal-title":"Endocr Relat Cancer"},{"key":"3550_CR68","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnins.2019.00521","volume":"13","author":"EM Rhea","year":"2019","unstructured":"Rhea EM, Banks WA. Role of the blood-brain barrier in central nervous system insulin resistance. Front Neurosci. 2019;13:521.","journal-title":"Front Neurosci"},{"key":"3550_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/JAD-170522","volume":"61","author":"SLC Geijselaers","year":"2018","unstructured":"Geijselaers SLC, Aalten P, Ramakers IHGB, De Deyn PP, Heijboer AC, Koek HL, et al. Association of cerebrospinal fluid (CSF) insulin with cognitive performance and CSF biomarkers of Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61:309\u201320.","journal-title":"J Alzheimers Dis"},{"key":"3550_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/srep43701","volume":"7","author":"LA Johnson","year":"2017","unstructured":"Johnson LA, Torres ERS, Impey S, Stevens JF, Raber J. Apolipoprotein E4 and insulin resistance interact to impair cognition and alter the epigenome and metabolome. Sci Rep. 2017;7:43701.","journal-title":"Sci Rep"},{"key":"3550_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, et al. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron. 2017;96:115\u201329.e5.","journal-title":"Neuron"},{"key":"3550_CR72","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1021\/acs.jproteome.9b00136","volume":"18","author":"K He","year":"2019","unstructured":"He K, Nie L, Zhou Q, Rahman SU, Liu J, Yang X, et al. Proteomic profiles of the early mitochondrial changes in APP\/PS1 and ApoE4 transgenic mice models of Alzheimer\u2019s disease. J Proteome Res. 2019;18:2632\u201342.","journal-title":"J Proteome Res"},{"key":"3550_CR73","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1523\/JNEUROSCI.5180-14.2015","volume":"35","author":"CC Liu","year":"2015","unstructured":"Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, et al. Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci. 2015;35:5851\u20139.","journal-title":"J Neurosci"},{"key":"3550_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.04.002","volume":"7","author":"Y Ding","year":"2016","unstructured":"Ding Y, Xian X, Holland WL, Tsai S, Herz J. Low-density lipoprotein receptor-related protein-1 protects against hepatic insulin resistance and hepatic steatosis. EBioMedicine. 2016;7:135\u201345.","journal-title":"EBioMedicine"},{"key":"3550_CR75","doi-asserted-by":"publisher","first-page":"11582","DOI":"10.3390\/ijms222111582","volume":"22","author":"H Gao","year":"2021","unstructured":"Gao H, Zheng W, Li C, Xu H. Isoform-specific effects of apolipoprotein e on hydrogen peroxide-induced apoptosis in human induced pluripotent stem cell (iPSC)-derived cortical neurons. Int J Mol Sci. 2021;22:11582.","journal-title":"Int J Mol Sci"},{"key":"3550_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/bbrc.2002.6586","volume":"292","author":"I Laffont","year":"2002","unstructured":"Laffont I, Takahashi M, Shibukawa Y, Honke K, Shuvaev VV, Siest G, et al. Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner. Biochem Biophys Res Commun. 2002;292:83\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"3550_CR77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psyneuen.2016.11.028","volume":"77","author":"MT Traversy","year":"2017","unstructured":"Traversy MT, Vandal M, Tremblay C, Tournissac M, Gigu\u00e8re-Rancourt A, Bennett AD, et al. Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene. Psychoneuroendocrinology. 2017;77:203\u201310.","journal-title":"Psychoneuroendocrinology"},{"key":"3550_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/srep03754","volume":"4","author":"QR Ong","year":"2014","unstructured":"Ong QR, Chan ES, Lim ML, Cole GM, Wong BS. Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci Rep. 2014;4:3754.","journal-title":"Sci Rep"},{"key":"3550_CR79","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.physbeh.2011.04.018","volume":"105","author":"L Shen","year":"2011","unstructured":"Shen L, Wang DQH, Tso P, Jandacek RJ, Woods SC, Liu M. Apolipoprotein E reduces food intake via PI3K\/Akt signaling pathway in the hypothalamus. Physiol Behav. 2011;105:124\u20138.","journal-title":"Physiol Behav"},{"key":"3550_CR80","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/01.RES.0000245479.03190.9f","volume":"99","author":"R DeKroon","year":"2006","unstructured":"DeKroon R, Robinette JB, Hjelmeland AB, Wiggins E, Blackwell M, Mihovilovic M, et al. APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase\/Akt Pathway via the phosphoinositol phosphatase SHIP2. Circ Res. 2006;99:829\u201336.","journal-title":"Circ Res"},{"key":"3550_CR81","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fnagi.2017.00435","volume":"9","author":"S Yang","year":"2017","unstructured":"Yang S, Pascual-Guiral S, Ponce R, Gim\u00e9nez-Llort L, Baltrons MA, Arancio O, et al. Reducing the levels of Akt activation by PDK1 knock-in mutation protects neuronal cultures against synthetic amyloid-beta peptides. Front Aging Neurosci. 2017;9:435.","journal-title":"Front Aging Neurosci"},{"key":"3550_CR82","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36:587\u201397.","journal-title":"Trends Neurosci"},{"key":"3550_CR83","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/0271678X17737012","volume":"39","author":"I Ruminot","year":"2019","unstructured":"Ruminot I, Schm\u00e4lzle J, Leyton B, Barros LF, Deitmer JW. Tight coupling of astrocyte energy metabolism to synaptic activity revealed by genetically encoded FRET nanosensors in hippocampal tissue. J Cereb Blood Flow Metab. 2019;39:513\u201323.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3550_CR84","doi-asserted-by":"publisher","first-page":"560375","DOI":"10.3389\/fendo.2020.560375","volume":"11","author":"J Berlanga-Acosta","year":"2020","unstructured":"Berlanga-Acosta J, Guill\u00e9n-Nieto G, Rodr\u00edguez-Rodr\u00edguez N, Bringas-Vega ML, Garc\u00eda-del-Barco-Herrera D, Berlanga-Saez JO, et al. Insulin resistance at the crossroad of Alzheimer disease pathology: a review. Front Endocrinol. 2020;11:560375.","journal-title":"Front Endocrinol"},{"key":"3550_CR85","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","volume":"14","author":"Y An","year":"2018","unstructured":"An Y, Varma VR, Varma S, Casanova R, Dammer E, Pletnikova O, et al. Evidence for brain glucose dysregulation in Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:318\u201329.","journal-title":"Alzheimers Dement"},{"key":"3550_CR86","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3389\/fnins.2019.00871","volume":"13","author":"N Bergau","year":"2019","unstructured":"Bergau N, Maul S, Rujescu D, Simm A, Navarrete Santos A. Reduction of glycolysis intermediate concentrations in the cerebrospinal fluid of Alzheimer\u2019s disease patients. Front Neurosci. 2019;13:871.","journal-title":"Front Neurosci"},{"key":"3550_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11064-020-02964-w","volume":"46","author":"LF Barros","year":"2021","unstructured":"Barros LF, Ruminot I, San Mart\u00edn A, Lerchundi R, Fern\u00e1ndez-Moncada I, Baeza-Lehnert F. Aerobic glycolysis in the brain: warburg and crabtree contra pasteur. Neurochem Res. 2021;46:15\u201322.","journal-title":"Neurochem Res"},{"key":"3550_CR88","doi-asserted-by":"publisher","first-page":"e19191","DOI":"10.1371\/journal.pone.0019191","volume":"6","author":"JT Newington","year":"2011","unstructured":"Newington JT, Pitts A, Chien A, Arseneault R, Schubert D, Cumming RC. Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS ONE. 2011;6:e19191.","journal-title":"PLoS ONE"},{"key":"3550_CR89","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1460-9568.2010.07584.x","volume":"33","author":"CR Figley","year":"2011","unstructured":"Figley CR, Stroman PW. The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals. Eur J Neurosci. 2011;33:577\u201388.","journal-title":"Eur J Neurosci"},{"key":"3550_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02722-z","volume":"20","author":"M Zy\u015bk","year":"2023","unstructured":"Zy\u015bk M, Beretta C, Naia L, Dakhel A, P\u00e5v\u00e9nius L, Brismar H, et al. Amyloid-\u03b2 accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism. J Neuroinflammation. 2023;20:43.","journal-title":"J Neuroinflammation"},{"key":"3550_CR91","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.18632\/aging.203330","volume":"13","author":"R Santangelo","year":"2021","unstructured":"Santangelo R, Giuffrida ML, Satriano C, Tomasello MF, Zimbone S, Copani A. \u03b2-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors. Aging. 2021;13:18033\u201350.","journal-title":"Aging"},{"key":"3550_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0896-6273(03)00367-2","volume":"39","author":"T Soucek","year":"2003","unstructured":"Soucek T, Cumming R, Dargusch R, Maher P, Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron. 2003;39:43\u201356.","journal-title":"Neuron"},{"key":"3550_CR93","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","volume":"38","author":"L Wu","year":"2018","unstructured":"Wu L, Zhang X, Zhao L. Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer\u2019s disease risk reduction and early intervention. J Neurosci. 2018;38:6665\u201381.","journal-title":"J Neurosci"},{"key":"3550_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01631-0","volume":"11","author":"W Fang","year":"2021","unstructured":"Fang W, Xiao N, Zeng G, Bi D, Dai X, Mi X, et al. APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline. Transl Psychiatry. 2021;11:507.","journal-title":"Transl Psychiatry"},{"key":"3550_CR95","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/cells12030410","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu L, Swerdlow RH, Zhao L. Opposing effects of ApoE2 and ApoE4 on glycolytic metabolism in neuronal aging supports a warburg neuroprotective cascade against Alzheimer\u2019s disease. Cells. 2023;12:410.","journal-title":"Cells"},{"key":"3550_CR96","doi-asserted-by":"publisher","first-page":"e17674","DOI":"10.1371\/journal.pone.0017674","volume":"6","author":"S John","year":"2011","unstructured":"John S, Weiss JN, Ribalet B. Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS ONE. 2011;6:e17674.","journal-title":"PLoS ONE"},{"key":"3550_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, Angulo SL, Khan U, Ashok A, Chen Q, Figueroa HY, et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat Commun. 2017;8:1464.","journal-title":"Nat Commun"},{"key":"3550_CR98","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1074\/jbc.M109.040428","volume":"285","author":"MP Jedrychowski","year":"2010","unstructured":"Jedrychowski MP, Gartner CA, Gygi SP, Zhou L, Herz J, Kandror KV, et al. Proteomic analysis of GLUT4 storage vesicles reveals LRP1 to be an important vesicle component and target of insulin signaling. J Biol Chem. 2010;285:104\u201314.","journal-title":"J Biol Chem"},{"key":"3550_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-S2-S16","volume":"9","author":"LC Costantini","year":"2008","unstructured":"Costantini LC, Barr LJ, Vogel JL, Henderson ST. Hypometabolism as a therapeutic target in Alzheimer\u2019s disease. BMC Neurosci. 2008;9:S16.","journal-title":"BMC Neurosci"},{"key":"3550_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03168.x","volume":"94","author":"K Pierre","year":"2005","unstructured":"Pierre K, Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem. 2005;94:1\u201314.","journal-title":"J Neurochem"},{"key":"3550_CR101","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","volume":"25","author":"MA Reger","year":"2004","unstructured":"Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004;25:311\u20134.","journal-title":"Neurobiol Aging"},{"key":"3550_CR102","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M B\u00e9langer","year":"2011","unstructured":"B\u00e9langer M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724\u201338.","journal-title":"Cell Metab"},{"key":"3550_CR103","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-150273","volume":"48","author":"AJ Hanson","year":"2015","unstructured":"Hanson AJ, Bayer JL, Baker LD, Cholerton B, VanFossen B, Trittschuh E, et al. Differential effects of meal challenges on cognition, metabolism, and biomarkers for apolipoprotein E \u025b4 carriers and adults with mild cognitive impairment. J Alzheimers Dis. 2015;48:205\u201318.","journal-title":"J Alzheimers Dis"},{"key":"3550_CR104","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000444079","volume":"6","author":"AJ Hanson","year":"2016","unstructured":"Hanson AJ, Banks WA, Hernandez Saucedo H, Craft S. Apolipoprotein E genotype and sex influence glucose tolerance in older adults: a Cross-Sectional Study. Dement Geriatr Cogn Dis Extra. 2016;6:78\u201389.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"3550_CR105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","volume":"16","author":"BC Farmer","year":"2021","unstructured":"Farmer BC, Williams HC, Devanney NA, Piron MA, Nation GK, Carter DJ, et al. APO\u03954 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis. Mol Neurodegener. 2021;16:62.","journal-title":"Mol Neurodegener"},{"key":"3550_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104742","volume":"136","author":"HC Williams","year":"2020","unstructured":"Williams HC, Farmer BC, Piron MA, Walsh AE, Bruntz RC, Gentry MS, et al. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiol Dis. 2020;136:104742.","journal-title":"Neurobiol Dis"},{"key":"3550_CR107","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/ijo.2016.93","volume":"40","author":"JM Arbones-Mainar","year":"2016","unstructured":"Arbones-Mainar JM, Johnson LA, Torres-Perez E, Garcia AE, Perez-Diaz S, Raber J, et al. Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4. Int J Obes. 2016;40:1574\u201381.","journal-title":"Int J Obes"},{"key":"3550_CR108","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jnc.15781","volume":"165","author":"RM Fleeman","year":"2023","unstructured":"Fleeman RM, Kuhn MK, Chan DC, Proctor EA. Apolipoprotein E \u03b54 modulates astrocyte neuronal support functions in the presence of amyloid-\u03b2. J Neurochem. 2023;165:536\u201349.","journal-title":"J Neurochem"},{"key":"3550_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102.","journal-title":"Nat Commun"},{"key":"3550_CR110","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello M, Pyakurel A, Glytsou C, Scorrano L. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020;21:204\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3550_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bse0470001","volume":"47","author":"PR Rich","year":"2010","unstructured":"Rich PR, Mar\u00e9chal A. The mitochondrial respiratory chain. Essays Biochem. 2010;47:1\u201323.","journal-title":"Essays Biochem"},{"key":"3550_CR112","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","volume":"28","author":"A Mary","year":"2023","unstructured":"Mary A, Eysert F, Checler F, Chami M. Mitophagy in Alzheimer\u2019s disease: molecular defects and therapeutic approaches. Mol Psychiatry. 2023;28:202\u201316.","journal-title":"Mol Psychiatry"},{"key":"3550_CR113","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41380-023-01956-w","volume":"28","author":"B Miller","year":"2023","unstructured":"Miller B, Kim SJ, Mehta HH, Cao K, Kumagai H, Thumaty N, et al. Mitochondrial DNA variation in Alzheimer\u2019s disease reveals a unique microprotein called SHMOOSE. Mol Psychiatry. 2023;28:1813\u201326.","journal-title":"Mol Psychiatry"},{"key":"3550_CR114","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41418-022-01027-7","volume":"29","author":"W Xie","year":"2022","unstructured":"Xie W, Guo D, Li J, Yue L, Kang Q, Chen G, et al. CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer\u2019s disease. Cell Death Differ. 2022;29:2417\u201328.","journal-title":"Cell Death Differ"},{"key":"3550_CR115","doi-asserted-by":"publisher","first-page":"e1592","DOI":"10.1212\/WNL.0000000000009249","volume":"94","author":"T Terada","year":"2020","unstructured":"Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, et al. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology. 2020;94:e1592\u2013604.","journal-title":"Neurology"},{"key":"3550_CR116","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z","volume":"48","author":"GE Gibson","year":"2000","unstructured":"Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, et al. Mitochondrial damage in Alzheimer\u2019s disease varies with apolipoprotein E genotype. Ann Neurol. 2000;48:297\u2013303.","journal-title":"Ann Neurol"},{"key":"3550_CR117","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-2010-100129","volume":"22","author":"J Valla","year":"2010","unstructured":"Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, et al. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE \u03b54 allele, the major late-onset Alzheimer\u2019s susceptibility gene. J Alzheimers Dis. 2010;22:307\u201313.","journal-title":"J Alzheimers Dis"},{"key":"3550_CR118","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1073\/pnas.0709259105","volume":"105","author":"WS Liang","year":"2008","unstructured":"Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, et al. Alzheimer\u2019s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA. 2008;105:4441\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR119","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.scr.2018.01.019","volume":"27","author":"JH Birnbaum","year":"2018","unstructured":"Birnbaum JH, Wanner D, Gietl AF, Saake A, Hock C, Nitsch RM, et al. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-beta and tau pathology in iPSC-derived neurons from sporadic Alzheimer\u2019s disease patients. Stem Cell Res. 2018;27:121\u201330.","journal-title":"Stem Cell Res"},{"key":"3550_CR120","first-page":"5148","volume":"25","author":"M Manczak","year":"2016","unstructured":"Manczak M, Kandimalla R, Fry D, Sesaki H, Reddy PH. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer\u2019s disease. Hum Mol Genet. 2016;25:5148\u201366.","journal-title":"Hum Mol Genet"},{"key":"3550_CR121","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona JC, Duchen MR. PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 2016;100:153\u201363.","journal-title":"Free Radic Biol Med"},{"key":"3550_CR122","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri A, Chandra A, Flint Beal M. PGC-1\u03b1, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radic Biol Med. 2013;62:37\u201346.","journal-title":"Free Radic Biol Med"},{"key":"3550_CR123","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1073\/pnas.1606171113","volume":"113","author":"L Katsouri","year":"2016","unstructured":"Katsouri L, Lim YM, Blondrath K, Eleftheriadou I, Lombardero L, Birch AM, et al. PPAR\u03b3-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA. 2016;113:12292\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR124","doi-asserted-by":"publisher","first-page":"e64019","DOI":"10.1371\/journal.pone.0064019","volume":"8","author":"JM Zolezzi","year":"2013","unstructured":"Zolezzi JM, Silva-Alvarez C, Ordenes D, Godoy JA, Carvajal FJ, Santos MJ, et al. Peroxisome proliferator-activated receptor (PPAR) \u03b3 and PPAR\u03b1 agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders? PLoS ONE. 2013;8:e64019.","journal-title":"PLoS ONE"},{"key":"3550_CR125","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"HK Chen","year":"2011","unstructured":"Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem. 2011;286:5215\u201321.","journal-title":"J Biol Chem"},{"key":"3550_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, Mi Y, Shi X, Gu H, Brinton RD, Yin F. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep. 2021;34:108572.","journal-title":"Cell Rep"},{"key":"3550_CR127","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1326-4-35","volume":"4","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Watanabe A, Fujino T, Hosono T, Michikawa M. Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol Neurodegener. 2009;4:35.","journal-title":"Mol Neurodegener"},{"key":"3550_CR128","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/cells13141207","volume":"13","author":"V Budny","year":"2024","unstructured":"Budny V, Kn\u00f6pfli Y, Meier D, Z\u00fcrcher K, Bodenmann C, Peter SL, et al. APOE4 increases energy metabolism in APOE-Isogenic iPSC-derived neurons. Cells. 2024;13:1207.","journal-title":"Cells"},{"key":"3550_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102331","volume":"217","author":"JV Andersen","year":"2022","unstructured":"Andersen JV, Schousboe A, Verkhratsky A. Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: integration of the glutamate\/GABA-glutamine cycle. Prog Neurobiol. 2022;217:102331.","journal-title":"Prog Neurobiol"},{"key":"3550_CR130","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85779","volume":"12","author":"ME Wynne","year":"2023","unstructured":"Wynne ME, Ogunbona O, Lane AR, Gokhale A, Zlatic SA, Xu C, et al. APOE expression and secretion are modulated by mitochondrial dysfunction. eLife. 2023;12:e85779.","journal-title":"eLife"},{"key":"3550_CR131","doi-asserted-by":"publisher","first-page":"27","DOI":"10.15252\/embr.201540614","volume":"17","author":"MD Tambini","year":"2016","unstructured":"Tambini MD, Pera M, Kanter E, Yang H, Guardia-Laguarta C, Holtzman D, et al. ApoE4 upregulates the activity of mitochondria-associated ER membranes. EMBO Rep. 2016;17:27\u201336.","journal-title":"EMBO Rep"},{"key":"3550_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110435","volume":"38","author":"K Lindner","year":"2022","unstructured":"Lindner K, Beckenbauer K, van Ek LC, Titeca K, de Leeuw SM, Awwad K, et al. Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Rep. 2022;38:110435.","journal-title":"Cell Rep"},{"key":"3550_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113183","volume":"42","author":"H Lee","year":"2023","unstructured":"Lee H, Cho S, Kim MJ, Park YJ, Cho E, Jo YS, et al. ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes. Cell Rep. 2023;42:113183.","journal-title":"Cell Rep"},{"key":"3550_CR134","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jns.2009.03.002","volume":"283","author":"JC Shenk","year":"2009","unstructured":"Shenk JC, Liu J, Fischbach K, Xu K, Puchowicz M, Obrenovich ME, et al. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer\u2019s disease. J Neurol Sci. 2009;283:199\u2013206.","journal-title":"J Neurol Sci"},{"key":"3550_CR135","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yjmcc.2018.12.004","volume":"127","author":"AU Joshi","year":"2019","unstructured":"Joshi AU, Ebert AE, Haileselassie B, Mochly-Rosen D. Drp1\/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington\u2019s disease. J Mol Cell Cardiol. 2019;127:125\u201333.","journal-title":"J Mol Cell Cardiol"},{"key":"3550_CR136","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","volume":"42","author":"A Ashraf","year":"2015","unstructured":"Ashraf A, Fan Z, Brooks DJ, Edison P. Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur J Nucl Med Mol Imaging. 2015;42:447\u201358.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3550_CR137","doi-asserted-by":"publisher","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","volume":"29","author":"AD Cohen","year":"2009","unstructured":"Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci. 2009;29:14770\u20138.","journal-title":"J Neurosci"},{"key":"3550_CR138","doi-asserted-by":"publisher","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","volume":"110","author":"TLS Benzinger","year":"2013","unstructured":"Benzinger TLS, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2013;110:E4502\u20134509.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR139","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA. 2009;106:7209\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3550_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.612","volume":"7","author":"S Evans","year":"2017","unstructured":"Evans S, Dowell NG, Tabet N, King SL, Hutton SB, Rusted JM. Disrupted neural activity patterns to novelty and effort in young adult APOE-e4 carriers performing a subsequent memory task. Brain Behav. 2017;7:e00612.","journal-title":"Brain Behav"},{"key":"3550_CR141","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/ADR-170006","volume":"1","author":"M Venzi","year":"2017","unstructured":"Venzi M, T\u00f3th M, H\u00e4ggkvist J, Bogstedt A, Rachalski A, Mattsson A, et al. Differential effect of APOE alleles on brain glucose metabolism in targeted replacement mice: an [18F]FDG-\u03bcPET study. J Alzheimers Dis Rep. 2017;1:169\u201380.","journal-title":"J Alzheimers Dis Rep"},{"key":"3550_CR142","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1038\/s41380-023-02289-4","volume":"28","author":"L Naia","year":"2023","unstructured":"Naia L, Shimozawa M, Bereczki E, Li X, Liu J, Jiang R, et al. Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models. Mol Psychiatry. 2023;28:3966\u201381.","journal-title":"Mol Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03550-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:35:58Z","timestamp":1757435758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03550-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3550"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03550-w","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}